Should you have breast reconstruction at the same time as your mastectomy, or wait?

What is the short answer on immediate or delayed breast reconstruction?

Immediate breast reconstruction starts during the mastectomy; delayed reconstruction happens later in a separate operation. Our answer is to choose the timing that keeps cancer treatment on schedule, fits your anatomy and leaves sound reconstruction options open. Some patients choose to stay flat and reconsider later.

NICE NG101 defines the two routes in those terms: reconstruction started in the same operation as mastectomy, or reconstruction done later. That definition matters because the word “immediate” can make the operation sound complete in one stage. In practice, breast reconstruction commonly involves further surgery, whichever route you choose.

Suitable options should be discussed with you, including the choice of no reconstruction. Staying flat is a valid decision, either as a long-term plan or as a way to keep future reconstruction open once treatment is complete.

Here is the clean comparison we use at the start of planning.

Swipe to see more →

Waiting gives you more time and may make cancer treatment sequencing simpler. Same-time reconstruction may preserve breast skin and reduce the need to live through a separate first reconstruction operation later. We do not treat either route as the default before the cancer plan is clear.

Same-time reconstruction changes the first operation

A patient suitable for a skin-sparing mastectomy may be able to keep much of the breast skin, then start reconstruction during the same operation. That can help with the breast shape, but it does not remove the need to think about later symmetry work, implant exchange, nipple reconstruction or revision surgery.

Skin-sparing mastectomy and nipple-sparing mastectomy are cancer safety decisions first. We look at where the cancer sits, what margins are needed and whether the skin or nipple can be preserved safely. The reconstruction plan then works within those limits.

At D B Ghosh, we weigh cancer clearance and reconstructive planning together because those choices meet in the operating theatre. A breast shape is planned around what can be safely left behind after mastectomy, not around what looks convenient on paper.

Efficiency does not equal completion. Immediate reconstruction may mean less scarring because existing breast skin can often be used, but recovery is longer than mastectomy alone. It may also give you less time to decide, which matters if you are still processing a new cancer diagnosis or comparing implant-based and flap options.

Cancer treatment timing drives much of the decision

Reconstruction timing is planned alongside cancer treatment, not after it. Radiotherapy, chemotherapy, lymph node results and surgical margins can all change the safest route.

Radiotherapy changes the reconstruction choice

Radiotherapy does not automatically rule out immediate breast reconstruction. NICE says immediate reconstruction should be offered to women advised to have mastectomy, including those who may need radiotherapy, unless other health problems rule out reconstructive surgery.

Even so, radiotherapy changes the conversation. Implant-based reconstruction may be affected more by radiotherapy than immediate flap reconstruction, so we separate those options carefully. A flap reconstruction uses your own tissue, while an implant reconstruction uses a breast implant, sometimes with a tissue expander as a first stage.

A tissue expander can be useful when the final treatment plan is still uncertain. It can also affect scan planning, including possible limits on MRI scans and changes to radiotherapy planning, so it needs to be discussed before consent.

Chemotherapy makes wound healing part of the plan

Chemotherapy can follow immediate reconstruction, but wound problems can delay further treatment after mastectomy or reconstruction. Cancer Research UK states that chemotherapy works best if started within 6 weeks of cancer surgery, so we take wound healing seriously when the cancer plan includes chemotherapy.

That does not mean reconstruction is the wrong choice. It means the operation must be judged against your healing risk, the likely need for chemotherapy and the consequence of a slow recovery.

Nodal results can alter the route

Sentinel lymph node biopsy and axillary surgery help clarify whether cancer has reached the lymph nodes under the arm. Those results may affect whether post-mastectomy radiotherapy becomes likely.

Margins matter too. If the cancer needs a wider clearance, or if final pathology may change the treatment plan, a staged route may protect options better than a single upfront reconstruction plan. The breast multidisciplinary team, including surgery, radiology, pathology and oncology, helps pull those strands together before a final route is agreed.

“

Ask whether the reconstruction plan could change after final pathology, because margins and nodal results often affect the safest route. That question helps separate what is fixed from what remains provisional.

Mr Debashis Ghosh Consultant Oncoplastic Breast Surgeon

Different patients suit different reconstruction routes

No one is choosing from the same menu. Your cancer details, anatomy, smoking status, weight, medical conditions, recovery capacity and personal priorities all shape the answer.

In London-based consultant breast and oncoplastic care, we often see patients seeking a second opinion because two reasonable plans have been discussed. That does not mean one plan is careless. It usually means the balance between cancer treatment, reconstruction type and staged surgery needs a clearer explanation.

At D B Ghosh, we sort the routes in a practical way:

• Immediate reconstruction may suit you if the cancer plan is clear, your healing risk is acceptable and the surgeon can preserve skin or nipple safely. It can work with implants, your own tissue or a combined approach.
• Delayed reconstruction may fit better if you need more time, if cancer treatment should be completed first, or if smoking, being very overweight or serious medical conditions raise the chance of wound problems.
• Delayed-immediate reconstruction sits between the two. A first-stage procedure, such as a tissue expander, may preserve the skin envelope while final pathology or radiotherapy planning becomes clearer.

Risk-reducing mastectomy is a different setting because there may be no active cancer treatment to sequence afterwards. Even then, anatomy, implant versus flap choice and your tolerance for more than one operation still matter.

“

If an expander is being considered, ask how it may affect MRI access and radiotherapy planning. Those practical details can shape whether a staged route is the better fit.

Mr Debashis Ghosh Consultant Oncoplastic Breast Surgeon

Your consent discussion must make the trade-offs explicit

Before you agree to a reconstruction plan, the priority is simple: the plan must protect cancer treatment and make future surgery realistic. Good consent does not bury uncertainty. It names what is known, what remains uncertain and what could change after pathology results.

Take these questions into the clinic and expect plain answers.

• Is radiotherapy likely in my case, and how would it affect an implant or flap reconstruction? The answer should separate implant-based reconstruction from your-own-tissue reconstruction.
• Could chemotherapy timing be affected if wound healing is slow? We would want that risk discussed before surgery, especially if chemotherapy is already expected.
• Is skin-sparing or nipple-sparing mastectomy safe for my cancer position and margins? Preservation is only useful when it does not compromise cancer surgery.
• How many stages might I need after the first operation? Ask about symmetry surgery, nipple reconstruction, implant exchange or later revision if those may apply.
• If I choose an implant, how will implant safety and device records be handled? The MHRA says breast implant details must be recorded in the Breast and Cosmetic Implant Registry. Breast implant-associated anaplastic large cell lymphoma, known as BIA-ALCL, should also be part of implant consent; the MHRA currently reports a UK rate of 1 per 12,187 breast implants and tissue expanders sold, with limits to that estimate.

Textured implants do not need to be removed just because they are textured, unless symptoms linked with the implant develop. Implant consent should be calm and specific, because rare risks belong in the decision without taking over the whole discussion.

The strongest reconstruction plan is the one that keeps cancer treatment on track and leaves the best realistic reconstruction route open. Timing matters because it decides what remains possible later.

Questions we get asked about reconstruction timing

Can I choose to stay flat after mastectomy and decide later?

Yes. You can choose no reconstruction, and you can also choose to stay flat while keeping later reconstruction as a possibility if it remains clinically suitable.

Does immediate reconstruction mean everything is finished in one operation?

No. More than one operation is commonly needed to complete breast reconstruction, whether reconstruction starts at mastectomy or happens later.

Can a tissue expander affect scans or radiotherapy planning?

Yes. A tissue expander may require changes to MRI scan access or radiotherapy planning, so we discuss that before using one as part of a staged plan.

Is delayed reconstruction still possible after radiotherapy?

Yes, reconstruction may still be possible after radiotherapy, although radiotherapy can affect tissue quality and reconstruction choices. The best option depends on your anatomy, previous treatment and surgical risk.

Should I ask for a second opinion if recommendations differ?

Yes, a second opinion can be useful when the timing, reconstruction type or radiotherapy plan is uncertain. The aim is a clearer decision, not a criticism of the first plan.

This is general information, not medical advice.